WHO Member States just extended negotiations on a critical Pandemic Agreement annex, risking a repeat of COVID-19’s deadly inequities unless they act decisively by May.
Story Snapshot
- Independent Panel urges finalization of PABS annex ahead of IGWG 6th Meeting in March 2026 to link pathogen data sharing with equitable benefits.
- IGWG5 in February 2026 ended productively but without agreement, prompting extension toward May WHA deadline.
- PABS operationalizes Article 12, mandating technology transfer and non-exclusive licensing amid North-South divides.
- Civil society critiques drafts for weakening binding obligations to voluntary terms, threatening global equity.
PABS Annex Origins in Post-COVID Reforms
WHO Member States launched Pandemic Agreement negotiations after COVID-19 exposed pathogen data imbalances. Article 12 requires sharing genetic sequences and materials linked to benefits like vaccines and treatments. Complex disputes relegated PABS to a separate annex. The World Health Assembly formed IGWG in 2025 to negotiate it. This framework draws from the Nagoya Protocol but seeks binding enforcement for faster, fairer responses.
IGWG5 Progress and Extension Decision
IGWG held its fifth meeting from February 9-14, 2026, in Geneva. Co-Chair Ambassador Tovar da Silva Nunes from Brazil praised countries’ commitment to streamline text. Discussions advanced on contentious elements through consultations. WHO announced resumption for March 23-28, 2026, confirming extension past IGWG5. Officials expressed confidence in meeting the May 2026 WHA deadline despite delays.
Independent Panel’s Urgent Call to Action
The Independent Panel for Pandemic Preparedness and Response issued a statement before IGWG6. It demands Member States agree on PABS to deliver Article 12’s promise. Key elements include non-exclusive licensing, technology transfer, and R&D cooperation. The panel highlights its oversight role, pushing binding terms over voluntary ones. This contrasts official optimism by stressing unresolved equity gaps from COVID-19.
Stakeholder Clashes on Binding vs Voluntary Terms
Developing countries demand mandatory benefits to counter historical inequities. Developed nations prefer flexible, voluntary arrangements. Medicines Law & Policy criticized IGWG5 drafts for diluting technology transfer to “mutually agreed terms.” IGWG Bureau facilitates amid North-South tensions. Private sector, labs, and databases join dialogues. WHA holds final approval power in May 2026.
WHO Member States have agreed to extend negotiations on the Pathogen Access and Benefit Sharing (PABS) annex to the WHO Pandemic Agreement, with discussions to resume in late-April ahead of its scheduled consideration by the World Health Assembly (#WHA79) in May. Press release:… pic.twitter.com/BkziETCmOV
— World Health Organization (WHO) (@WHO) March 28, 2026
Implications for Global Pandemic Preparedness
Short-term delays risk stalling the entire Pandemic Agreement. Long-term success enables rapid data sharing with benefits flowing to origin countries. Developing nations gain vaccine access; pharma adapts to licensing rules. Socially, it narrows access gaps; politically, it tests WHO cooperation.
Sources:
A call to WHO Member States: agree a PABS Annex and deliver on the promise of the Pandemic Agreement
WHO: Global commitment on display as countries negotiate key annex to the Pandemic Agreement
Global Policy Journal article on Pandemic Agreement negotiations
Medicines Law & Policy statement at WHO PABS negotiations IGWG-5
